journal article·2018-10-31Open access

Pharmaceutical aspects of silver nanoparticles

Prateek Mathur, Swati Jha, Suman Ramteke, N. K. Jain

Abstract

Silver nanoparticles are particles in the size ranging between 1 and 100 nm. The two major methods used for synthesis of silver nanoparticle are the physical and chemical methods with the disadvantage that they are expensive and can also have toxicity. Biological method is being used as an expedient alternative, as this approach is environment-friendly and less toxic and it includes plant extracts, microorganism, fungi, etc. The major applications of silver nanoparticles in the medical field include diagnostic applications and therapeutic applications, apart from its antimicrobial activity. Due to their nanotoxicity, AgNPs have a several drawbacks too. This review presents a complete view of the mechanism of action, synthesis, the pharmacokinetics of silver nanoparticles, different formulations of AgNPs used in biomedical applications, infertility management, antibacterial effects, skin damage, burns, cancer treatment, etc. and various applications of silver nanoparticles together with the possible toxicological challenge.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, School of Pharmaceutical Sciences, Rajiv Gandhi Technical University

References (81)

Show source-provided references
1. 10.1016/j.reprotox.2017.01.00510.1016/j.reprotox.2017.01.005 ↗
2. Rafique M, Sadaf I, Rafique MS, et al. A review on green synthesis of silver nanoparticles and their applications. Artif Cells Nanomed Biotechnol. 2016;45:1–20.
3. 10.1016/j.scitotenv.2016.02.19010.1016/j.scitotenv.2016.02.190 ↗
4. 10.1021/la201200r10.1021/la201200r ↗
5. 10.1016/j.scitotenv.2016.10.04110.1016/j.scitotenv.2016.10.041 ↗
6. 10.1089/sur.2008.994110.1089/sur.2008.9941 ↗
7. 10.1021/es103316q10.1021/es103316q ↗
8. 10.1016/j.jare.2015.02.00710.1016/j.jare.2015.02.007 ↗
9. 10.3390/ijms1709153410.3390/ijms17091534 ↗
10. 10.1186/2228-5326-2-3210.1186/2228-5326-2-32 ↗
11. 10.1016/j.biotechadv.2008.09.00210.1016/j.biotechadv.2008.09.002 ↗
12. 10.1002/wnan.130410.1002/wnan.1304 ↗
13. 10.1208/s12248-016-0010-310.1208/s12248-016-0010-3 ↗
14. 10.1111/j.1365-2230.1980.tb01708.x10.1111/j.1365-2230.1980.tb01708.x ↗
15. 10.1289/ehp.090139810.1289/ehp.0901398 ↗
16. 10.1016/j.yrtph.2013.11.00210.1016/j.yrtph.2013.11.002 ↗
17. 10.1097/00004032-196812000-0000510.1097/00004032-196812000-00005 ↗
18. 10.1021/nn302649p10.1021/nn302649p ↗
19. Patil PS, Kumbhar TS. Antioxidant, antibacterial and cytotoxic potential of silver nanoparticles synthesized using terpenes rich extract of Lantana camara L. leaves. Biochem Biophys Rep. 2017;10:76–81.
20. 10.1080/1061186X.2017.130653410.1080/1061186X.2017.1306534 ↗
21. 10.1016/j.molliq.2017.01.00410.1016/j.molliq.2017.01.004 ↗
22. 10.1016/j.ijbiomac.2017.07.04710.1016/j.ijbiomac.2017.07.047 ↗
23. 10.1016/j.ejps.2016.11.00610.1016/j.ejps.2016.11.006 ↗
24. 10.1021/acs.jafc.5b0455910.1021/acs.jafc.5b04559 ↗
25. 10.1016/j.carbpol.2016.05.04110.1016/j.carbpol.2016.05.041 ↗
26. 10.1016/j.jphotobiol.2016.01.00210.1016/j.jphotobiol.2016.01.002 ↗
27. 10.1016/j.apsusc.2016.05.13310.1016/j.apsusc.2016.05.133 ↗
28. 10.1016/j.molliq.2016.08.06410.1016/j.molliq.2016.08.064 ↗
29. 10.1080/21691401.2016.120225710.1080/21691401.2016.1202257 ↗
30. 10.1080/10942912.2016.118882610.1080/10942912.2016.1188826 ↗
31. 10.1016/j.exppara.2015.12.01110.1016/j.exppara.2015.12.011 ↗
32. 10.1007/s40204-015-0042-210.1007/s40204-015-0042-2 ↗
33. 10.2147/IJN.S8127110.2147/IJN.S81271 ↗
34. 10.1080/17518253.2014.89585910.1080/17518253.2014.895859 ↗
35. 10.1007/s00436-014-3895-810.1007/s00436-014-3895-8 ↗
36. 10.1016/j.actatropica.2011.03.00310.1016/j.actatropica.2011.03.003 ↗
37. 10.1016/j.molliq.2016.03.03810.1016/j.molliq.2016.03.038 ↗
38. 10.1016/j.jiec.2016.11.02910.1016/j.jiec.2016.11.029 ↗
39. 10.1016/j.ijbiomac.2017.05.03010.1016/j.ijbiomac.2017.05.030 ↗
40. 10.1016/j.colsurfb.2017.02.01210.1016/j.colsurfb.2017.02.012 ↗
41. 10.1080/00914037.2016.125235810.1080/00914037.2016.1252358 ↗
42. 10.1208/s12249-017-0832-z10.1208/s12249-017-0832-z ↗
43. 10.1007/s10853-016-0565-510.1007/s10853-016-0565-5 ↗
44. 10.1016/j.biopha.2017.04.01710.1016/j.biopha.2017.04.017 ↗
45. 10.1016/j.msec.2017.04.14910.1016/j.msec.2017.04.149 ↗
46. 10.1038/s41598-017-05461-310.1038/s41598-017-05461-3 ↗
47. 10.1039/C6SC04127B10.1039/C6SC04127B ↗
48. 10.1016/j.procbio.2017.11.00310.1016/j.procbio.2017.11.003 ↗
49. 10.1016/j.procbio.2017.11.00310.1016/j.procbio.2017.11.003 ↗
50. 10.3109/17435390.2015.111332110.3109/17435390.2015.1113321 ↗
51. Swanner J, Fahrenholtz C, Singh R. Abstract B04: systemic delivery of silver nanoparticles and targeting of the folate receptor alpha for the treatment of triple-negative breast cancer. Mol Cancer Res. 2016;14:B04.10.1158/1557-3125.ADVBC15-B04 ↗
52. 10.1080/09205063.2015.111689210.1080/09205063.2015.1116892 ↗
53. 10.1063/1.490732210.1063/1.4907322 ↗
54. 10.1007/s13346-016-0322-y10.1007/s13346-016-0322-y ↗
55. 10.1016/j.nano.2016.01.02110.1016/j.nano.2016.01.021 ↗
56. 10.1039/C6NR07976H10.1039/C6NR07976H ↗
57. 10.1016/j.bios.2015.09.00210.1016/j.bios.2015.09.002 ↗
58. 10.1039/C5LC00055F10.1039/C5LC00055F ↗
59. 10.1016/j.nano.2015.12.37810.1016/j.nano.2015.12.378 ↗
60. 10.1021/ac504527410.1021/ac5045274 ↗
61. 10.1049/iet-nbt.2015.000810.1049/iet-nbt.2015.0008 ↗
62. 10.1016/j.msec.2015.11.03610.1016/j.msec.2015.11.036 ↗
63. Rath G, Hussain T, Chauhan G, et al. Collagen nanofiber containing silver nanoparticles for improved wound-healing applications. J Drug Target. 2015;24:1–10.
64. 10.1039/c3tb20806k10.1039/c3tb20806k ↗
65. 10.2147/IJN.S3239110.2147/IJN.S32391 ↗
66. 10.1021/ac302639c10.1021/ac302639c ↗
67. 10.1016/j.biomaterials.2010.10.04210.1016/j.biomaterials.2010.10.042 ↗
68. 10.1016/j.canlet.2011.06.02210.1016/j.canlet.2011.06.022 ↗
69. 10.1021/ja909108x10.1021/ja909108x ↗
70. George C, Kuriakose S, Kumar P, et al. Synthesis, characterization and antibacterial applications of water soluble silver nanoparticle encapsulated β cyclodextrin. J Supramol Chem. 2010;22(9):511–516.
71. 10.1021/nn700048y10.1021/nn700048y ↗
72. 10.1021/jp062536y10.1021/jp062536y ↗
73. 10.3109/1040841X.2014.91220010.3109/1040841X.2014.912200 ↗
74. 10.1016/j.arabjc.2010.04.00810.1016/j.arabjc.2010.04.008 ↗
75. 10.1186/s11671-016-1257-410.1186/s11671-016-1257-4 ↗
76. 10.1055/s-0042-11338310.1055/s-0042-113383 ↗
77. 10.1016/j.plaphy.2016.08.00710.1016/j.plaphy.2016.08.007 ↗
78. 10.1016/j.fct.2014.12.01910.1016/j.fct.2014.12.019 ↗
79. 10.1212/01.WNL.0000120671.73335.EC10.1212/01.WNL.0000120671.73335.EC ↗
80. 10.1007/s10529-008-9786-210.1007/s10529-008-9786-2 ↗
81. 10.1111/j.1365-2249.2008.03831.x10.1111/j.1365-2249.2008.03831.x ↗